What happened
Original notice title
Tobin's Royal Stag, Inc. dba Tobin Farms Velvet Antler 4/19/17
From the archived source record
Based on our inspection, laboratory analysis of samples of in-process products and materials, and review of your website and product labeling collected during the inspection, we identified serious violations of the Federal Food, Drug and Cosmetic Act (the Act) and its implementing regulations. Unapproved New Drugs and Misbranded Drugs FDA reviewed your product brochure and website at the Internet address tobinfarms.com in January 2017 and determined that you take orders on your website for the products Velvet Antler Capsules and Velvet Antler Powder. A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, your Velvet Antler Capsules and Velvet Antler Powder fail to bear adequate directions for their intended use and, therefore, the products are misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]. The introduction or delivery for introduction into interstate commerce of these misbranded drugs violates section 301(a) of the Act [21 U.S.C. 331(a)]. Unapproved New Animal Drugs In addition, the claims on videos embedded in your website at tobinfarms.com establish that your Velvet Antler capsules and Velvet Antler powder products are intended for use in the cure, mitigation, treatment, or prevention of diseases in animals, which makes them drugs under section 201(g)(1)(B) of the Act [21 U.S.C. § 321(g)(1)(B)]. Further, as discussed below, these products are unapproved new animal drugs and introducing or delivering these products for introduction into interstate commerce violates the Act. Therefore, these products are unsafe within the meaning of section 512(a) of the Act, [21 U.S.C. § 360b(a)], and adulterated under section 501(a)(5) of the Act [21 U.S.C. § 351(a)(5)].
What the official notice says to do
Check the original notice for the instructions that apply to the named product, company, and affected lots.
Read the official notice →Status and source details
- Status recorded in the archive
- Historical warning letter; closeout not established by annual index
- Source checked
- Jul 16, 2026
- Record revision
- 7f7a1181733e
This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.
Sources, dates, and coverage →